Akèy › Ipèsansibilite arachid › Maryland
Etid klinik pou Ipèsansibilite arachid nan Maryland
3 etid pou Ipèsansibilite arachid ap chèche patisipan nan sit nan Maryland.
Tèks ofisyèl etid la (Anglè)
A 52-week Study of Remibrutinib in IgE-mediated Food Allergy
- Institute for Asthma and Allergy PC, Chevy Chase
Ap rekriteFaz 3
Laj 12 a 65 · Tout sèks · Mizajou Sep 25, 2026 · NCT07768371Efficacy of Tezepelumab in Peanut Oral Immunotherapy
- Johns Hopkins Children's Center: Department of Allergy & Immunology, Baltimore
Ap rekriteFaz 2
Laj 12 a 55 · Tout sèks · Mizajou Sep 16, 2026 · NCT07015996Study of Oral Food Challenge Biomarkers (SAFER)
- Johns Hopkins Children's Center: Department of Allergy & Immunology, Baltimore
Ap rekriteEtid obsèvasyon
12 Months – 17 Years · Tout sèks · Mizajou Sep 9, 2026 · NCT07279467Sous ClinicalTrials.gov, done yo ranmase Oct 2, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.